Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2014/04/004531
CTRI/2014/04/004531
Not yet recruiting
未知

A clinical study on the management of Rheumatoid Arthritis with Shiva Guggulu and Kottam Chukkadi Taila

Institute for Post Graduate Teaching and Research in Ayurveda0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- patients suffering from Rheumatoid Arthritis

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- patients suffering from Rheumatoid Arthritis
Sponsor
Institute for Post Graduate Teaching and Research in Ayurveda
Enrollment
50
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Institute for Post Graduate Teaching and Research in Ayurveda

Eligibility Criteria

Inclusion Criteria

  • •patients fulfilling the diagnostic criteria
  • •Age between 20 to 60 years
  • •willing and able to participate in the study

Exclusion Criteria

  • •Chronicity more than 10 years
  • •A patients who have severe complications of Rheumatoid Arthritis
  • •A patients having gouty Arthritis
  • •poorly controlled HTN And DM
  • •Patients on prolong allopathy medication like steroids
  • •pregnant and lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 1
Exploratory study for the treatment of rheumatoid arthritis by eliminating dampnessRheumatoid Arthritis
ITMCTR2000003354Guangdong Provincial Hospital of Chinese Medicine
Recruiting
Not Applicable
The clinical assessment of rheumatoid arthritis using FDG-PETRheumatoid Arthritis
JPRN-UMIN000006061Gunma University40
Completed
Not Applicable
Follow-up study of patients with rheumatoid arthritis who treated infliximab for 1 year and did not reach a clinical remission in RRRR StudyRheumatoid Arthritis
JPRN-UMIN000007539niversity of Occupational and Environmental Health, Japan108
Active, not recruiting
Phase 1
REDO study: Research into the effects of lower doses rituximab in patients with rheumatoid arthritis
EUCTR2016-002908-15-NLSint Maartenskliniek140
Completed
Not Applicable
Clinical outcome in patients with rheumatoid arthritis switched to tumor nesrosis factor blockers after tocilizumab or abataceptrheumatoid arthritis
JPRN-UMIN000016950Osaka Medical College50